Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis.


Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
08 2021
Historique:
received: 25 01 2021
accepted: 07 04 2021
pubmed: 25 5 2021
medline: 11 8 2021
entrez: 24 5 2021
Statut: ppublish

Résumé

Infection with coronavirus disease-2019 (COVID-19) may predispose for venous thromboembolism (VTE). There is wide variation in reported incidence rates of VTE in COVID-19, ranging from 3% to 85%. Therefore, the true incidence of thrombotic complications in COVID-19 is uncertain. Here we present data on the incidence of VTE in both hospitalised and non-hospitalised patients from two ongoing prospective cohort studies. The incidence of VTE after diagnosis of COVID-19 was 3·9% [95% confidence interval (CI): 2·1-7·2] during hospitalisation, 0·9% (95% CI: 0·2-3·1) in the three months after discharge and 0·2% (95% CI: 0·00-1·25) in non-hospitalised patients, suggesting an incidence rate at the lower end of that in previous reports.

Identifiants

pubmed: 34028814
doi: 10.1111/bjh.17522
pmc: PMC8239792
doi:

Substances chimiques

Anticoagulants 0
Heparin, Low-Molecular-Weight 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

542-546

Informations de copyright

© 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.

Références

Thromb Res. 2020 Oct;194:116-118
pubmed: 32788102
Thromb Res. 2020 Dec;196:67-74
pubmed: 32853978
J Thromb Haemost. 2020 Jun;18(6):1421-1424
pubmed: 32271988
Br J Haematol. 2020 Jun;189(5):846-847
pubmed: 32304577
Thromb Res. 2021 Feb;198:135-138
pubmed: 33338976
Thorax. 2021 Apr;76(4):405-407
pubmed: 33273028
Eur Respir J. 2021 Apr 29;57(4):
pubmed: 33303540
Thromb Res. 2021 Jan;197:94-99
pubmed: 33190025
J Thromb Haemost. 2020 Aug;18(8):1995-2002
pubmed: 32369666
EClinicalMedicine. 2020 Dec;29:100639
pubmed: 33251499
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2332-2337
pubmed: 32628040

Auteurs

Birgitte Tholin (B)

Clinic of Internal Medicine, Østfold Hospital, Gralum, Norway.

Waleed Ghanima (W)

Clinic of Internal Medicine, Østfold Hospital, Gralum, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Haematology, Oslo University Hospital, Oslo, Norway.

Gunnar Einvik (G)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Pulmonary Medicine, Akershus University Hospital, Lørenskog, Norway.

Bernt Aarli (B)

Department of Thoracic Medicine, Haukeland University Hospital, Haukeland, Norway.
Department of Clinical Science, University of Bergen, Bergen, Norway.

Eivind Brønstad (E)

Thoracic Department, St. Olavs Hospital, Trondheim, Norway.
Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway.

Ole H Skjønsberg (OH)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway.

Knut Stavem (K)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Pulmonary Medicine, Akershus University Hospital, Lørenskog, Norway.
Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH